NGF but not GDNF or neurturin enhance acetylcholine tissue levels in striatal organotypic brain slices

International Journal of Developmental Neuroscience

Volumn 16, Issue 5, 1998, Pages 391-401

  Fischer, H P ^a   Marksteiner, J ^a   Ransmayr, G ^a   Saria, A ^a   Humpel, C ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Acetylcholine; GDNF; Growth factor; Neurturin; NGF; Striatum; Survival; Trophic

Indexed keywords

ACETYLCHOLINE; CHOLINE ACETYLTRANSFERASE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; MUSCARINIC M2 RECEPTOR; NERVE GROWTH FACTOR;

ARTICLE; BRAIN SLICE; CHOLINERGIC NERVE CELL; CORPUS STRIATUM; INTERNEURON; PRIORITY JOURNAL;

ACETYLCHOLINE; ANIMALS; AXOTOMY; CHOLINE; CORPUS STRIATUM; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; INTERNEURONS; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURTURIN; ORGAN CULTURE TECHNIQUES; RATS;

EID: 0031740344     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(98)00039-2     Document Type: Article

References (59)

1. Barbacid M. (1993) Nerve growth factor: a tale of two receptors. Oncogene 8, 2033-2042.
2. Barde Y. A. (1990) The nerve growth factor family. Progr. Growth Factor Res. 2, 237-248.
3. Bradshaw R. A., Blundell T. L., Lapatto R., Mcdonald N. Q. and Murrayrust J. (1993) Nerve growth factor revisited. Trends Biochem. Sci. 18, 48-52.
4. Levi-Montalcini R., Aloe L. and Alleva E. (1990) A role for nerve growth factors in nervous, endocrine and immune systems. Prog. Neuroendocrinol. 3, 1-10.
5. Levi-Montalcini R. and Angeletti P. U. (1968) Nerve growth factor. Physiol. Rev. 48, 534-569.
6. Levi-Montalcini R., Dal Toso R., Della Valle F., Skaper S. D. and Leon A. (1995) Update of the NGF saga. J. Neurol. Sci. 130, 119-127.
7. Thoenen H. and Barde Y.-A. (1980) Physiology of nerve growth factor. Physiol. Rev. 60, 1284-1335.
8. Pallage V., Knusel B., Hefti F. and Will B. (1993) Functional consequences of a single nerve growth factor administration following septal damage in rats. Eur. J. Neurosci. 5, 669-679.
9. Winn S. R., Hammang J. P., Emerich D. F., Lee A., Palmiter R. D. and Baetge E. E. (1994) Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc. Natl. Acad. Sci. U.S.A. 91, 2324-2328.
10. Yunshao H., Zhibin Y. and Yici C. (1991) Effect of nerve growth factor on the lesioned septohippocampal cholinergic system of aged rats. Brain Res. 552, 159-163.
11. Kew J. N. C., Smith D. W. and Sofroniew M. V. (1996) Nerve growth factor withdrawal induces the apoptotic death of developing septal cholinergic neurons in vitro: protection by cyclic AMP analogue and high potassium. Neurosci. 70, 329-339.
12. Seiger A., Nordberg A., Von Holst H., Bäckman L., Ebendal T., Alafuzoff I., Amberla K., Hartvig P., Herlitz A., Lilja A., Lundqvist H., Langström B., Meyerson B., Persson A., Viitanen M., Winblad B. and Olson L. (1993) Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Beh. Brain Res. 57, 255-261.
13. Mobley W. C., Rutkowski J. L., Tennekoon G. I., Buchanan K. and Johnston M. V. (1985) Choline acetyltransferase activity in striatum of neonatal rats is increased by nerve growth factor. Science 229, 284-287.
14. Williams L. R. and Rylett R. L. (1990) Exogenous nerve growth factor increases the activity of high-affinity choline uptake and choline acetyltransferase in brain of Fisher 344 male rats. J. Neurochem. 55, 1042-1049.
15. Abiru Y., Nishio C. and Hatanaka H. (1996) The survival of striatal cholinergic neurons cultured from postnatal 2-week-old rats is promoted by neurotrophins. Dev. Brain Res. 91, 260-267.
16. Studer L., Spenger C., Luthman J. and Seiler R. W. (1994) NGF increases neuritic complexity of cholinergic interneurons in organotypic cultures of neonatal rat striatum. J. Comp. Neurol. 340, 281-296.
17. Förander P., Söderström S., Humpel C. and Strömberg I. (1996) Chronic infusion of nerve growth factor into rat striatum increases cholinergic markers and inhibits striatal neuronal discharge rate. European Journal Neuroscience 8, 1822-1832.
18. Williams L., Varon S., Peterson G., Wictorin K., Fischer W., Björklund A. and Gage F. (1986) Continuous infusion of nerve growth factor prevents basal forebrain neuronal cell death after fimbria fornix transection. Proc. Natl. Acad. Sci U.S.A. 83, 9231-9235.
19. Lin L. F. H., Doherty D. H., Lile J. D., Bektesh S. and Collins F. (1993) GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
20. Strömberg I., Björklund L., Johansson M., Tomac A., Collins F., Olson L., Hoffer B. and Humpel C. (1993) Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol. 124, 401-412.
21. Nosrat C. A., Tomac A., Lindqvist E., Lindskog S., Humpel C., Strömberg I., Ebendal T., Hoffer B. J. and Olson L. (1996) Cellular expression of GDNF mRNA suggets multiple functions inside and outside the nervous system. Cell Tissue Res. 286, 191-207.
22. Choi-Lundberg D. L. and Bohn M. C. (1995) Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Dev. Brain Res. 85, 80-88.
23. Schaar D. G., Sieber B.-A., Dreyfus C. F. and Black I. B. (1993) Regional and cell-specific expression of GDNF in rat brain. Exp. Neurol. 124, 368-371.
24. Tomac A., Widenfalk J., Lin L. F. H., Kohno T., Ebendal T., Hoffer B. and Olson L. (1995) Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. Natl. Acad. Sci. U.S.A. 92, 8274-8278.
25. Barbin G., Selak I., Manthorpe M. and Varon S. (1984) Use of central neuronal cultures for the detection of neuronotrophic agents. Neurosci. 12, 33-43.
26. Hudson J., Granholm A. C., Gerhardt G. A., Henry M. A., Hoffman A., Biddle P., Leela N. S., Mackerlova L., Lile J. D., Collins F. and Hoffer B. J. (1995) Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36, 425-432.
27. Kearns C. M. and Gash D. M. (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672, 104-111.
28. Tomac A., Lindqvist E., Lin L. F. H., Ögren S. O., Young D., Hoffer B. J. and Olson L. (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 335-339.
29. Yan Q., Matheson C. and Lopez O. T. (1995) In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373, 341-344.
30. Arenas E., Trupp M., Akerud P. and Ibanez C. F. (1995) GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15, 1465-1473.
31. Williams L. R., Inouye G., Cummins V. and Pelleymounter M. A. (1996) Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: dose-response comparison to nerve growth factor and brain-derived neurotrophic factor. J. Pharmacol. Exp. Ther. 277, 1140-1151.
32. Humpel C., Marksteiner J. and Saria A. (1996) Glial-cell-line-derived neurotrophic factor enhances biosynthesis of substance P in striatal neurons in vitro. Cell Tissue Res. 286, 249-255.
33. Wang Y., Lin S.-Z., Chiou A.-L., Williams L. R. and Hoffer B. J. (1997) Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J. Neurosci. 17, 4341-4348.
34. Kotzbauer P. T., Lampe P. A., Heuckeroth R. O., Golden J. P., Creedon D. J., Johnson E. M. J. and Milbrandt J. (1996) Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature 384, 467-470.
35. Hutter P., Johansson M., Saria A. and Humpel C. (1996) Acute and chronic noradrenergic regulation of neurotrophin messenger RNA expression in rat hippocampus: evidence from lesions and organotypic cultures. Neuroscience 70, 15-29.
36. Stoppini L., Buchs P. A. and Muller D. (1991) A simple method for organotypic cultures of nervous tissue. J. Neurosci. Meth. 37, 173-182.
37. Damsma G., Lammerts van Eueren D., Westerink B. H. C. and Horn A. S. (1987) Determination of acetylcholine and choline in the femtomol range by means of HPLC, a postcolumn enzyme reactor and electrochemical detection. Chromatographia 24, 827-831.
38. Prast H. and Philippu A. (1992) Release of endogenous acetylcholine in the hypothalamus of conscious rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 346, 1-3.
39. Brice A., Berrard S., Raynaud B., Ansieau S., Coppola T., Weber M. J. and Mallet J. (1989) Complete sequence of a cDNA encoding an active rat choline acetyltransferase: a tool to investigate the plasticity of cholinergic phenotype expression. J. Neurosci. Res. 23, 266-273.
40. Bernard V., Normand E. and Bloch B. (1992) Phenotypic characterization of the striatal neurons expressing muscarinic receptor genes. J. Neurosci. 12, 3591-3600.
41. Weiner D. M., Levey A. I. and Brann M. R. (1990) Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc. Natl. Acad. Sci. 87, 7050-7054.
42. Bruce G., Wainer B. H. and Hersh L. B. (1985) Immunoaffinity purification of human choline acetyltransferase: comparison of the brain and placental enzymes. J. Neurochem. 45, 611-620.
43. Ostergaard K., Jones S. A., Hyman C. and Zimmer J. (1996) Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures. Exp. Neurol. 142, 340-350.
44. Ostergaard K. (1993) Organotypic slice cultures of rat striatum - I. A histochemical and immunohistochemical study of acetylcholinesterase, choline acetyltransferase, glutamate decarboxylase and GABA. Neurosci. 53, 679-693.
45. Ostergaard K., Finsen B. and Zimmer J. (1995) Organotypic slice cultures of the rat striatum: an immunocytochemical, histochemical and in situ hybridization study of somatostatin, neuropeptide Y, nicotinamide adenine dinucleotide phosphate-diaphorase and enkephalin. Exp. Brain Res. 103, 70-84.
46. Liu F.-C., Takahashi H., McKay R. D. G. and Graybiel A. M. (1995) Dopaminergic regulation of transcription factor expression in organotypic cultures of developing striatum. J. Neurosci. 15, 2367-2384.
47. Steininger T. L., Wainer B. H., Klein R., Barbacid M. and Palfrey H. C. (1993) High affinity nerve growth factor receptor (trk) immunoreactivity is localized in cholinergic neurons of the basal forebrain and striatum in the adult rat brain. Brain Res. 612, 330-335.
48. Kariko K., Barnathan E. S., Lee V. M. Y., Rangel Y., Langer D. J. and Welsh F. A. (1997) High level of protein expression achieved by mRNA transfection in cultured neurons and in brain in vivo. Society Neurosci. 23, 142.6.
49. Widenfalk J., Nosrat C., Tomac A., Westphal H., Hoffer B. and Olson L. (1997) Neurturin and glial cell line-derived neurotrophic factor receptor-beta (GDNFR-beta), novel proteins related to GDNF and GDNFR-alpha with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs. J. Neurosci. 17, 8506-8519.
50. Ventimiglia, R., Mather, P. E., Jones, B. E. and Lindsay, R. M. (1995) The neurotrophins BDNF, NT-3, and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur. J. Neurosci., 7.
51. Ohga Y., Zirrgiebel U., Hamner S., Michaelidis T. M., Cooper J., Thoenen H. and Lindholm D. (1996) Cell density increases bcl-2 and bcl-x expression in addition to survival of cultured cerebellar granule neurons. Neurosci. 73, 913-917.
52. Alexi T., Venero J. L. and Hefti F. (1997) Protective effects of neurotrophin-4/5 and transforming growth factor-alpha on striatal neuronal phenotypic degeneration after excitotoxic lesioning with quinolinic acid. Neurosci. 78, 73-86.
53. Weise B., Janet T. and Grothe C. (1993) Localization of bFGF and FGF-receptor in the developing nervous system of the embryonic and newborn rat. J. Neurosci. Res. 34, 442-453.
54. Walicke P. A. (1988) Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions. J. Neurosci. 8, 2618-2627.
55. Garcia-Segura L. M., Perez J., Pons S., Rejas M. T. and Torres-Aleman I. (1991) Localization of insulin-like growth factor I (IGF-I)-like immunoreactivity in the developing and adult rat brain. Brain Res. 560, 167-174.
56. Yamaguchi F., Itano T., Mizobuchi M., Miyamoto O., Janjua N. A., Matsui H., Tokuda M., Ohmoto T., Hosokawa K. and Hatase O. (1990) Insulin-like growth factor I (IGF-I) distribution in the tissue and extracellular compartment in different regions of rat brain. Brain Res. 533, 344-347.
57. Sara V. R., Carlsson-Skwirut C., Bergman T., Jornvall H., Roberts P. J., Crawford M., Hakansson L. N., Civalero I. and Nordberg A. (1989) Identification of Gly-Pro-Glu (GPE), the aminoterminal tripeptide of insulin-liek growth factor 1 which is truncated in brain, as a novel neuroactive peptide. Biochem. Biophys. Res. Comm. 165, 766-771.
58. Hoffer B. J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L.-F. H. and Gerhardt G. (1994) Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182, 107-111.
59. Mount H. T. J., Dean D. O., Alberch J., Dreyfus C. F. and Black I. B. (1995) Glial cell line-derived neurotrophic factor promotes the survival and morphologic differentiation of Purkinje cells. Proc. Natl. Acad. Sci. U.S.A. 92, 9092-9096.